Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients

NCT00902421 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Selective serotonin reuptake inhibitors
DRUG: Antimuscarinics

Sponsor

Samsung Medical Center